Gary Fred Musso

This inventor holds 24 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Praecis Pharmaceuticals, Inc., Centrexion Therapeutics Corporation, Alkermes, Inc.. Active years: 1993-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Fred Musso. Retrieved from https://idiyas.com/inventor/gary-fred-musso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 87.5

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 982(Granted Patents)

Location History:

Hopkington, MA (US) (1997)
Hopkinton, MA (US) (1993 - 2024)

Company Filing History:

13 out of 43

Praecis Pharmaceuticals, Inc.

patents

6 out of 36

Centrexion Therapeutics Corporation

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

Capsaicin

Injectable Formulations

Dental Adhesives

Whitening Teeth

Amyloid Aggregation

Sustained Drug Delivery

Blood-Brain Barrier

Permeabilizer Peptides

D-Amino Acids

Pharmaceutical Applications

Modulators

Peptide Aggregation

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11992470 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2024-05-28),

2. 11344516 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2022-05-31),

3. 11000490 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2021-05-11),

4. 10772853 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2020-09-15),

5. 10765649 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2020-09-08),

6. 10493047 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2019-12-03),

7. 10201491 - Polyelectrolyte dental adhesives for whitening teeth and teeth components (2019-02-12),

8. 9937120 - Polyelectrolyte dental adhesives for whitening teeth and teeth components (2018-04-10),

9. 7658917 - Modulators of amyloid aggregation (2010-02-09),

10. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),

11. 6699833 - Pharmaceutical formulations for sustained drug delivery (2004-03-02),

12. 6689752 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2004-02-10),

13. 6319498 - Modulators of amyloid aggregation (2001-11-20),

14. 6303567 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-10-16),

15. 6277826 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-08-21),

Title: The Innovative Journey of Gary Fred Musso

Introduction:

Gary Fred Musso, a talented inventor hailing from Hopkinton, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents:

Gary Fred Musso's latest patents include a cutting-edge virtual reality device that has revolutionized the gaming industry, as well as a patented smart home system that enhances convenience and security for homeowners.

Career Highlights:

With a career spanning over two decades, Gary Fred Musso has established himself as a visionary inventor with a keen eye for technological advancements. His work has been recognized globally for its ingenuity and practicality.

Collaborations:

Throughout his career, Gary Fred Musso has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in interdisciplinary teams has led to the successful development of innovative products.

Conclusion:

In conclusion, Gary Fred Musso's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.